The news today on BBC should help stop T3 being withdrawn on the basis of Price. Good news:
Drug company Concordia overcharged the NHS by millions for a key thyroid treatment, the Competition and Markets Authority has provisionally found.
The CMA said that last year the NHS spent £34m on its drug, liothyronine, up from about £600,000 in 2006.
The amount the NHS paid per pack rose from around £4.46 in 2007 to £258.19 by July 2017, an increase of almost 6,000%.